Found: 1
Select item for more details and to access through your institution.
Smad3 deficiency improves islet-based therapy for diabetes and diabetic kidney injury by promoting β cell proliferation via the E2F3-dependent mechanism.
- Published in:
- Theranostics, 2022, v. 12, n. 1, p. 379, doi. 10.7150/thno.67034
- By:
- Publication type:
- Article